Pipelines for NewCo & Licensing
Welcome to Unibest's Pipeline Insights, your gateway to cutting-edge pharmaceutical innovation. In this blog collection, we unveil our open pipelines for NewCo development and licensing opportunities, offering valuable insights into promising molecular targets, innovative drug candidates, and the diseases we aim to conquer. Whether you're a potential partner, investor, or industry enthusiast, explore how Unibest is shaping the future of medicine through groundbreaking research and collaborative opportunities. Dive into our collection to discover how we're working to transform patient care and contribute to global health improvements, one pipeline at a time.

screenshot-20250416-163751.png
Unibest Unveils Innovative 505(b)(2) Project for Semaglutide: UB-PEP-104

In the ever-evolving landscape of pharmaceutical innovation, Unibest is proud to announce a groundbreaking development in the administration of Semaglutide, codenamed UB-PEP-104.

READ MORE
1NKP.png
Targeting c-Myc and a Molecular Glue: UB-TBD-025

The transcription factor c-Myc has emerged as a critical target in oncology, given its aberrant expression in more than 70% of human cancers. Unibest presents a first-in-class small molecule glue targeting c-Myc open for NewCo.

READ MORE
Reteplase vs Alteplase - Rankin Scale.jpg
Reteplase: A Proven Superior Thrombolytic Agent for Acute Ischemic Stroke

We, Unibest, are excited to share with you the remarkable benefits and opportunities that Reteplase brings to the global market.

READ MORE
IL-11, reteplase and EPO.png
Three Recombinant Protein Products for Global Licensing

Unibest is proud to partner with a renowned Chinese Pharmaceutical company and announce the following global licensing opportunities:1.

READ MORE
rhEPO product.png
rhEPO: From Biochemistry To Commercial

Thrombolytic drugs play a crucial role in treating various venous and arterial thromboembolic conditions, particularly acute myocardial infarction.

READ MORE
Anticoagulant Market.png
Heparin Market: A Comprehensive Guide to Sources, Types, and Clinical Applications

Heparin is one of the oldest biological drugs used in treating thrombosis and hemostasis. It is a naturally occurring polysaccharide in the glycosaminoglycan (GAG) family, found primarily in mast cells.

READ MORE
il-11 product.png
Oprelvekin: A Unique Opportunity to Address Critical Unmet Needs in Cancer Care

With the development of chemotherapy agents, we've witnessed remarkable strides in the development of chemotherapy agents, resulting in improved efficacy and reduced side effects. However, a critical challenge persists that demands our attention: the management of chemotherapy-induced thrombocytopenia.

READ MORE